Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kenvue Inc. Common Stock (NY:KVUE)

15.29 +1.18 (+8.36%)
Official Closing Price Updated: 7:00 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Kenvue Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Options Corner: Despite Political Woes, Kenvue Can Still Make Tylenol Great Again
While Kenvue's Tylenol has attracted intense political pressure, speculators are determined to make KVUE stock great again. 
Via Benzinga
A Congress Member Sold Up To $330K In UnitedHealth Group Stock: Here's What You Need To Know
 
Via Benzinga
Should You Buy Kenvue Stock After Its 30% Plunge?
There hasn't been much good news lately for this Johnson & Johnson spinoff. 
Via The Motley Fool
Topics Government Lawsuit
Cullen Trims KVUE Stake With $149.5M Share Sale
Via The Motley Fool
Topics Regulatory Compliance
Kenvue Stock To Face More Headwinds? Trump’s Tylenol Warning Revives Autism Lawsuits, Retail Bulls Stay Unfazed
Via Stocktwits
Topics Government Lawsuit
Why Is Kenvue Stock Rising Premarket Today?
Via Stocktwits
Why Is Kenvue Stock Rising Today?
Via Stocktwits
Kenvue Stock Hits Record Low As Trump Urges Pregnant Women To ‘Fight Like Hell’ Against Tylenol: Retail Stays Bullish
Via Stocktwits
Topics Government
Kenvue Shares Drop Ahead Of Trump’s ‘Biggest Announcement’ On Autism: Reports Say Administration To Link Tylenol With Risk Of Disease
Via Stocktwits
Topics Government
Friday's session: most active stock in the S&P500 index
Looking for the most active S&P500 stocks in today's session? Join us as we dive into the US markets on Friday and discover the stocks that are dominating the trading activity and setting the pace for... 
Via Chartmill
Demystifying Kenvue: Insights From 11 Analyst Reviews
Kenvue (NYSE: KVUE) underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. In the table below, you'll find a summary of their recent ratings,... 
Via Benzinga
White House Highlights A Controversial 2017 Tylenol Tweet On Its Usage During Pregnancy: 'We Actually Don't Recommend...'
A 2017 post by Tylenol on X (formerly Twitter) highlighted by White House has fueled a buzz around President Donald Trump‘s claim that the drug is linked with autism in kids. 
Via Benzinga
Kenvue Bounces Off Record Low: A Deep Dive into its Rebound and Future Prospects
Kenvue (NYSE: KVUE), the consumer health giant spun off from Johnson & Johnson, has experienced a significant rebound in its stock price, climbing notably from a recent record low. This resurgence... 
Via MarketMinute
Topics Government Product Recall
What's going on in today's session: S&P500 movers
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Wednesday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
Wednesday's session: most active stock in the S&P500 index
Looking for the most active S&P500 stocks in today's session? Join us as we dive into the US markets on Wednesday and discover the stocks that are dominating the trading activity and setting the pace... 
Via Chartmill
Kenvue Surges Over 2% Pre-Market Despite Trump Administration's Autism Warning
Kenvue's stock rose 2.61% to $17.69 in pre-market trading on Wednesday, despite concerns sparked by President Trump's comments linking acetaminophen to autism. 
Via Benzinga
Topics Government
Jon Stewart Roasts Trump Over 'Acetaminophen' Pronunciation: 'We Would Like A Second Opinion'
Trump struggles to pronounce acetaminophen while warning pregnant women of its potential link to autism. Jon Stewart mocks his incompetence. 
Via Benzinga
Topics Government
Nvidia, Plug Power, Micron, Kenvue, Kroger: What Sparked Heavy After-Hours Trading In These 5 Stocks?
Micron stock showed a muted reaction to earnings despite the quarterly numbers and guidance exceeding expectations. 
Via Stocktwits
Topics Artificial Intelligence
Trump’s Tylenol Warning Sparks FDA Action, But Kenvue Stock Climbs: Retail Traders See ‘Huge Buying Opportunity’
Kenvue is facing renewed litigation risks, activist investor pressure, and a challenging consumer backdrop as it undertakes a portfolio review under interim CEO Kirk Perry. 
Via Stocktwits
Topics Economy Government Lawsuit
These S&P500 stocks are the most active in today's session
Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Tuesday and uncover the stocks that are leading the way in terms of trading volume and market... 
Via Chartmill
Curious about which S&P500 stocks are generating unusual volume on Tuesday? Find out below.
In today's session, there are S&P500 stocks with remarkable trading volume. Explore the stocks exhibiting unusual volume in Tuesday's session. 
Via Chartmill
What's Going On With Kenvue Stock Tuesday?
Kenvue shares are trading higher Tuesday despite Trump saying the Food and Drug Administration will notify physicians that use of acetaminophen or Tylenol during pregnancy could be associated with... 
Via Benzinga
Topics Government
Kenvue On Track To Bounce Back From Record Lows — What’s Driving Stock Higher In Premarket?
Many doctors reportedly disagreed with the Trump administration’s Tylenol claims and warned that these unfounded claims would likely impair maternal health. 
Via Stocktwits
Topics Government Lawsuit
Stock Market Today: Nasdaq Futures Rise, S&P 500 Slips Amid Mixed Trade—Kenvue, Micron Tech, Nvidia In Focus
U.S. stock futures were fluctuating on Tuesday following Monday's record advances. Futures of major benchmark indices were mixed. 
Via Benzinga
Topics Stocks
Jim Cramer Says Trump Is Creating 'A Nightmare' For Kenvue As President Links Tylenol With Autism
Jim Cramer says Trump creates a "nightmare" for Kenvue after linking Tylenol to autism. Learn why KVUE stock is plunging amid lawsuit fears. 
Via Benzinga
Topics Government Lawsuit
Nvidia’s $100B Bet in OpenAI Pushes Wall Street to Fresh Records
Tech did the heavy lifting as Nvidia and Apple dragged indexes over the finish line; gold hit yet another all-time high while oil sagged. The Fed chorus grew louder and more discordant. 
Via Chartmill
Topics Economy
Johnson & Johnson Stock Weathers Trump’s Tylenol Attacks Better Than Kenvue Amid Dipping Retail Confidence — What’s Holding Losses in Check?
Guggenheim’s upgrade and new data on J&J’s experimental depression drug helped steady sentiment, even as investors weighed political scrutiny and ongoing litigation risks. 
Via Stocktwits
Topics Government
Nvidia, Kenvue, Rivian, MicroCloud Hologram And Opendoor: Why These 5 Stocks Are On Investors' Radars Today
U.S. stocks closed higher on Monday, with the Dow Jones Industrial Average edging up 0.14% to 46,381.54. 
Via Benzinga
Topics Stocks
Which S&P500 stocks are moving on Monday?
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday. 
Via Chartmill
Curious about the most active S&P500 stocks in today's session?
Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Monday. Discover the stocks that are generating the highest... 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.